OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity
Xiuting Liu, Graham D. Hogg, Chong Zuo, et al.
Cancer Cell (2023) Vol. 41, Iss. 6, pp. 1073-1090.e12
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

NF-κB in biology and targeted therapy: new insights and translational implications
Qing Guo, Yizi Jin, Xinyu Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 423

Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives
Xiaoli Shi, Xinyi Wang, Wentao Yao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 33

Macrophage plasticity: signaling pathways, tissue repair, and regeneration
Lingfeng Yan, Jue Wang, Xin Cai, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 28

Roles and inhibitors of FAK in cancer: current advances and future directions
Hui-Hui Hu, Saiqi Wang, Hai-Li Shang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 24

Novel tumor-associated macrophage populations and subpopulations by single cell RNA sequencing
Juanjuan Wang, Ningning Zhu, Lei Su, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 23

The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia
Mingyang Liu, Yu Ren, Zhijun Zhou, et al.
Cancer Cell (2024) Vol. 42, Iss. 5, pp. 885-903.e4
Open Access | Times Cited: 21

Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer
Loretah Chibaya, Kelly D. DeMarco, Christina F. Lusi, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 762
Open Access | Times Cited: 13

Embracing diversity: macrophage complexity in cancer
Jan Hochstadt, Sabino Pacheco, María Casanova-Acebes
Trends in cancer (2025)
Closed Access | Times Cited: 1

Sex differences and immune correlates of Long Covid development, symptom persistence, and resolution
Rebecca E. Hamlin, S. Pienkos, Leslie Chan, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 773
Open Access | Times Cited: 7

Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer
Yifan Fu, Jinxin Tao, Tao Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6

Targeting cGAS/STING signaling-mediated myeloid immune cell dysfunction in TIME
Vijay Kumar, Caitlin Bauer, John H. Stewart
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 16

Potential therapeutic targets in myeloid cell therapy for overcoming chemoresistance and immune suppression in gastrointestinal tumors
Jiawei Fan, Jianshu Zhu, He Zhu, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 198, pp. 104362-104362
Open Access | Times Cited: 5

Signaling by Type I Interferons in Immune Cells: Disease Consequences
Μαρκέλλα Ζαννίκου, Eleanor N. Fish, Leonidas C. Platanias
Cancers (2024) Vol. 16, Iss. 8, pp. 1600-1600
Open Access | Times Cited: 5

Integrins in Health and Disease—Suitable Targets for Treatment?
Tanja Klaus, Christoph Hieber, Matthias Bros, et al.
Cells (2024) Vol. 13, Iss. 3, pp. 212-212
Open Access | Times Cited: 4

IGFBP2 induces podocyte apoptosis promoted by mitochondrial damage via integrin α5/FAK in diabetic kidney disease
Xiaochen Wang, Yifan Zhang, Kun Chi, et al.
APOPTOSIS (2024) Vol. 29, Iss. 7-8, pp. 1109-1125
Closed Access | Times Cited: 4

Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: Molecular mechanisms and therapeutic targets
Yutong Zhao, C.M. Qin, Lin Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189183-189183
Closed Access | Times Cited: 4

Plasma membrane-coated nanoparticles and membrane vesicles to orchestrate multimodal antitumor immunity
Yusuke Ito, Hitomi Kasuya, Mirei Kataoka, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010005-e010005
Open Access

Multicenter Study to Establish RNA-Based Risk Model for Nasopharyngeal Carcinoma Distant Metastasis
Zhaozheng Hou, Ping Feng, Chi‐Leung Chiang, et al.
(2025)
Closed Access

Age-Associated B Cells in Autoimmune Diseases: Pathogenesis and Clinical Implications
Guangyang Xie, Xiaojing Chen, Yanli Gao, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Open Access

The role of type I interferon signaling in myeloid anti-tumor immunity
Sofie Patrizia Meyer, Rebekka Bauer, Bernhard Brüne, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Multifaceted, unique role of CD11c in leukocyte biology
Lifei Hou, Sophia Koutsogiannaki, Koichi Yuki
Frontiers in Immunology (2025) Vol. 16
Open Access

The cGAS-STING pathway in cancer immunity: dual roles, therapeutic strategies, and clinical challenges
Beilei Yue, Wenbo Gao, Jonathan F. Lovell, et al.
Essays in Biochemistry (2025) Vol. 69, Iss. 02
Open Access

Targeting GOLPH3L improves glioblastoma radiotherapy by regulating STING-NLRP3–mediated tumor immune microenvironment reprogramming
Shuo Sun, Shiyu Qian, Ran Wang, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 788
Closed Access

NLRP4 unlocks an NK/macrophages-centered ecosystem to suppress non-small cell lung cancer
Zhouwenli Meng, Jian Li, Hui Wang, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access

Page 1 - Next Page

Scroll to top